Why I think Appen Ltd looks a buy at this share price

The Appen Ltd (ASX:APX) share price had a good run in 2017. And it looks set to continue its climb.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Appen Ltd (ASX: APX) share price gained almost 200 per cent in the past year and there are signs it could continue to deliver strong returns in 2018.

Appen utilises data sets and machine learning to provide services that are aimed at improving search engines, social media platforms, eCommerce sites and fraud detection operations, among others.

The company has established a global presence and continues to expand.

Appen recently acquired California-based Leapforce and Raterlabs Inc which facilitate working from home services that seek to evaluate search engine results.

Leapforce was set to generate US$58 million in revenue and US$13.6 million in EBITDA in 2017.

Appen stated that it expects the deal to be at least 35 per cent accretive to underlying earnings per share.

That would add to already impressive results.

Appen reported revenue for the first half of 2017 of $74.1 million, an increase of 39 per cent on the prior corresponding period, and net profit after tax of $8.1 million, up 50 per cent.

The company, with a market value of $877 million, also stated that it expects full-year EBITDA for the year ending 31 December 2017 to be as high as 50 per cent above the prior year's results.

Based on Appen's EBITDA of $17.2 million for the year ending 31 December 2016, that could come in at around $25.8 million.

Appen's shares may appear pricey, changing hands for more than 60x trailing earnings.

But Appen is in different league to most ASX tech companies, particularly when stacked against others with a hand in the artificial intelligence space such a Brainchip Holdings Ltd (ASX: BRN) and Bigtincan Holdings Ltd (ASX: BTH).

And although some analysts are not so keen on Appen, it still looks like it has a lot of potential.

Motley Fool contributor Steve Holland has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended BIGTINCAN FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »